AVGO three-lens brief
Evidence-based stock research on AVGO. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $531.85 — 47% above current (47 analysts). · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $531.85 — 47% above current (47 analysts).
- 8-K filing filed 2026-09-02.
- Reported earnings on 2026-09-02.
- Ex-dividend date 2026-09-21.
AVGO closed at $360.83 (-0.97%) as of 2026-09-11. Market cap: $1.72T. P/E (trailing) 46.5. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $531.85 — 47% above current (47 analysts).; 97% of directional headlines were bullish (5 recent articles scanned).. Concerns: trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $29.59B, net income $13.09B, free cash flow $30.50B.
Why three lenses on AVGO, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AVGOacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AVGO" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AVGO brief"></iframe>